Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PLAAFM: Fentanyl vs Morphine on Aspirin Platelet Response
NCT05367336Phase 2Terminated
- Sponsor
- Corewell Health
- Start
- Aug 2022
- Primary completion
- Feb 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of fentanyl, morphine in chest pain, sponsored by Corewell Health. Started Aug 2022; status: terminated.
02
Drugs
fentanylmorphine
03
Conditions
chest pain
Beyond the preview
Go deeper on NCT05367336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05367336.